The global postoperative pain therapeutics market size was valued at US$ 11,459.3 Mn in 2018 and to reach US$ 17 BN by 2027. The global postoperative pain therapeutics market is projected to expand at a CAGR of nearly 4.8% from 2020 to 2027.
High incidence and severity of postoperative pain, introduction of promising drugs, increase in the number of surgical procedures, and high rate of adoption of pain management in developed as well as pharmerging countries are spurring the growth of the global postoperative pain therapeutics market. North America and Europe are projected to be prominent regions in the global postoperative pain therapeutics market during the forecast period. The postoperative pain therapeutics market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. The growth of the postoperative pain therapeutics market in the region is attributed to the high rate of adoption of pain management, rise in disposable income, and increase in the number of surgical procedures. The postoperative pain therapeutics market in Latin America is likely to grow at a moderate pace during the forecast period.
High Incidence and Severity of Postoperative Pain, Introduction of Promising Drugs, and High Adoption Rate of Pain Management in Developed as well as Pharmerging Countries to Drive the Postoperative Pain Therapeutics Market
Opioids Projected to be a Highly Lucrative Drug Class in the Postoperative Pain Therapeutics Market
Oral Route of Administration Leads in the Postoperative Pain Therapeutics Market
Hospital Pharmacies Segment Prominent in the Postoperative Pain Therapeutics Market
Asia Pacific Presents Significant Opportunities in the Postoperative Pain Therapeutics Market
The report analyzes and forecasts the postoperative pain therapeutics market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of postoperative pain therapeutics, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major postoperative pain therapeutics companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of postoperative pain therapeutics upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of postoperative pain therapeutics and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global postoperative pain therapeutics market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the postoperative pain therapeutics market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of postoperative pain therapeutics market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Some of the key market giants holding a sizeable chunk of the global postoperative pain therapeutics market share include Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Camurus AB, and a few others.
Segmentation
By Drug Types
Opioids
NSAIDS
Local Anesthetics
Tricyclic Antidepressants
Antiepileptic Drugs
Others
Route of Administration
Oral
Intramuscular
Intravenous
Others
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Postoperative Pain Therapeutics Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Postoperative Pain Therapeutics Market Analysis and Forecast, 2017–2026
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Regulatory Scenario Assessment
5.2. Overview of Total Surgical Procedures Requiring Postoperative Pain Management
5.3. Pipeline Analysis
5.4. Healthcare industry Overview
6. Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Drug Class, 2017–2026
6.3.1. Opioids
6.3.2. NSAIDS
6.3.3. Tricyclic Antidepressants
6.3.4. Antiepileptic Drugs
6.3.5. Local Anesthetics
6.3.6. Others
6.4. Market Attractiveness, by Drug Class
7. Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Mode of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Mode of Administration, 2017–2026
7.3.1. Oral
7.3.2. Intravenous
7.3.3. Intramuscular
7.3.4. Others
7.4. Market Attractiveness, by Mode of Administration
8. Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2017–2026
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.3.4. Others
8.4. Market Attractiveness, by Distribution Channel
9. Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Postoperative Pain Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Drug Class, 2017–2026
10.2.1. Opioids
10.2.2. NSAIDS
10.2.3. Tricyclic Antidepressants
10.2.4. Antiepileptic Drugs
10.2.5. Local Anesthetics
10.2.6. Others
10.3. Market Value Forecast, by Mode of Administration, 2017–2026
10.3.1. Oral
10.3.2. Intravenous
10.3.3. Intramuscular
10.3.4. Others
10.4. Market Value Forecast, by Distribution Channel, 2017–2026
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Drug Class
10.6.2. By Mode of Administration
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Postoperative Pain Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Drug Class, 2017–2026
11.2.1. Opioids
11.2.2. NSAIDS
11.2.3. Tricyclic Antidepressants
11.2.4. Antiepileptic Drugs
11.2.5. Local Anesthetics
11.2.6. Others
11.3. Market Value Forecast, by Mode of Administration, 2017–2026
11.3.1. Oral
11.3.2. Intravenous
11.3.3. Intramuscular
11.3.4. Others
11.4. Market Value Forecast, by Distribution Channel, 2017–2026
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Drug Class
11.6.2. By Mode of Administration
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Postoperative Pain Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Drug Class, 2017–2026
12.2.1. Opioids
12.2.2. NSAIDS
12.2.3. Tricyclic Antidepressants
12.2.4. Antiepileptic Drugs
12.2.5. Local Anesthetics
12.2.6. Others
12.3. Market Value Forecast, by Mode of Administration, 2017–2026
12.3.1. Oral
12.3.2. Intravenous
12.3.3. Intramuscular
12.3.4. Others
12.4. Market Value Forecast, by Distribution Channel, 2017–2026
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Drug Class
12.6.2. By Mode of Administration
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Postoperative Pain Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Drug Class, 2017–2026
13.2.1. Opioids
13.2.2. NSAIDS
13.2.3. Tricyclic Antidepressants
13.2.4. Antiepileptic Drugs
13.2.5. Local Anesthetics
13.2.6. Others
13.3. Market Value Forecast, by Mode of Administration, 2017–2026
13.3.1. Oral
13.3.2. Intravenous
13.3.3. Intramuscular
13.3.4. Others
13.4. Market Value Forecast, by Distribution Channel, 2017–2026
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Drug Class
13.6.2. By Mode of Administration
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Postoperative Pain Therapeutics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Drug Class, 2017–2026
14.2.1. Opioids
14.2.2. NSAIDS
14.2.3. Tricyclic Antidepressants
14.2.4. Antiepileptic Drugs
14.2.5. Local Anesthetics
14.2.6. Others
14.3. Market Value Forecast, by Mode of Administration, 2017–2026
14.3.1. Oral
14.3.2. Intravenous
14.3.3. Intramuscular
14.3.4. Others
14.4. Market Value Forecast, by Distribution Channel, 2017–2026
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Drug Class
14.6.2. By Mode of Administration
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Company Profiles
15.1. Mallinckrodt Pharmaceuticals
15.2. Pacira BioSciences, Inc.
15.3. Trevena, Inc.
15.4. Heron Therapeutics
15.5. Pfizer, Inc.
15.6. Teva Pharmaceutical Industries Ltd.
15.7. Novartis AG
15.8. Camarus
15.9. Eli Lilly & Company
15.10. Mallinckrodt Pharmaceuticals
15.11. Bayer AG
15.12. Others